Delivery Order SPE2DB22D2005-SPE2DB25FJQH4
- Not listed
- The Defense Logistics Agency awarded a $581,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. Under this single day contract, Amerisourcebergen will supply 8,000 boxes of the 0.05-0.25 mg dosage patches to a Conshohocken, Pennsylvania facility from August 21-22, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for the combination estrogen and progestin patches supports the...
- The Defense Logistics Agency awarded a $628.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will provide 8 units of Combipatch transdermal patches containing 0.05-0.14 mg of estradiol and norethindrone acetate to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a 3-day period concluding on August 21,...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,138.25 to provide COMBIPATCH 0.05-0.14 MG PTCH 8S, a pharmaceutical product. This award is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
- The Defense Logistics Agency awarded a $630 delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. Under this firm fixed price contract, Amerisourcebergen will provide approximately 630,000 dollars worth of COMBIPATCH 0.05-0.14 mg transdermal patches to the DLA. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three day period in mid-August 2023. No subcontractors or set aside designations were identified. This...
- The Defense Logistics Agency awarded a $745.31 firm fixed price delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. As the prime contractor, Amerisourcebergen will deliver the medication to the DLA under a one-day period of performance beginning July 10th and concluding on July 11th, 2023. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. No subcontractors or set aside designations were indicated. This order is likely...
- The Defense Logistics Agency awarded a $1,559 delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH 0.05-0.14 MG PTCH 8S. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide transdermal combination hormone replacement patches to support DLA and Department of Defense medical readiness programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from August 14 to...
- The Defense Logistics Agency awarded a $1,418 delivery order to Amerisourcebergen Drug Corporation for COMBIPATCH transdermal patches. The firm fixed price order is for a one-day period of performance from August 7-8, 2023 at the contractor's facility in Conshohocken, Pennsylvania. No additional details were provided regarding the Defense Logistics Agency's requirement or associated contract vehicle. Amerisourcebergen will fulfill the order as the prime contractor without involvement of major...
- The Defense Logistics Agency awarded a $315,240 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of COMBIPATCH transdermal patches. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the medication to support DLA procurement programs. The single day performance period is scheduled from August 10-11, 2023 at Amerisourcebergen's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.82 firm fixed-price delivery order is for the supply of "COMBIPATCH 0.05-0.14 MG PTCH 8S", a pharmaceutical product, with a period of performance through March 26, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,298.88 firm fixed-price delivery order is for the supply of COMBIPATCH 0.05-0.14 MG PTCH 8S medical patches, with a period of performance through November 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQH4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.19 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of CombiPatch 0.05-0.14 mg transdermal patches (8-count unit). This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-set-aside competitive award executed under DLA's pharmaceutical supply operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the Defense Health Agency's medical supply chain, fulfilling orders through the DLA Troop Support Medical indefinite delivery contract (SPE2DX) valued at $999,999,999.00 through December 2026. This delivery order is a child transaction under AmerisourceBergen Drug Corp's prime indefinite delivery contract with DLA Troop Support Medical, which functions as a comprehensive global pharmaceutical support vehicle. The contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. CombiPatch, a combination hormone replacement therapy product, is among the diverse therapeutic categories the vendor provides through this vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/24/25 |